Literature DB >> 7130395

Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture.

H H Zingg, Y C Patel.   

Abstract

The neuronal biosynthesis of somatostatin-like immunoreactivity (SLI) was investigated using mechanically dispersed neonatal rat hypothalamic cells kept in culture for up to 6 wk. Immunohistochemically, SLI was specifically localized to a small subpopulation of parvicellular neurons and their cell processes. By radioimmunoassay the cellular SLI content declined steadily during the first 2 wk in culture (nadir value of 60 fmol/dish at day 15) but then increased progressively to reach a maximum value of 381 fmol/dish at day 46. Gel chromatographic analysis showed this immunoreactivity to consist of forms corresponding to tetradecapeptide somatostatin (S-14), somatostatin-28 (S-28), and a 15,000-mol-wt molecule. After incubation of the cells with [3H]phenylalanine, the cellular extracts, purified by adsorption to C18 silica, contained material that bound specifically to an immobilized antisomatostatin antibody. Analysis by gel chromatography and high performance liquid chromatography of the specifically bound label provided evidence for the presence of labeled S-14, S-28, and the 15,000-mol-wt molecule. Pulse-chase experiments (20-min pulse, 20-min chase) demonstrated a transfer of radioactivity from the 15,000-mol-wt form to material corresponding to S-14 as well as to S-28. These studies demonstrate that cultured hypothalamic neurons are capable of synthesizing three somatostatin-like peptides (15,000-mol-wt SLI, S-28, S-14), one of which (15,000-mol-wt SLI) serve as a biosynthetic precursor for both S-28 and S-14. This in vitro system should provide a powerful tool for further investigation of the biosynthesis and regulation of biosynthesis of somatostatin in the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130395      PMCID: PMC370323          DOI: 10.1172/jci110698

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Use of octadecasilyl-silica for the extraction and purification of peptides in biological samples. Application to the identification of circulating metabolites of corticotropin-(1-24)-tetracosapeptide and somatostatin in vivo.

Authors:  H P Bennett; A M Hudson; C McMartin; G E Purdon
Journal:  Biochem J       Date:  1977-10-15       Impact factor: 3.857

2.  Cellular localization of somatostatin.

Authors:  R Elde; T Hökfelt; O Johansson; M Schultzberg; S Efendić; R Luft
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

3.  Synthesis, transport, and release of posterior pituitary hormones.

Authors:  M J Brownstein; J T Russell; H Gainer
Journal:  Science       Date:  1980-01-25       Impact factor: 47.728

4.  Higher molecular weight forms of immunoreactive somatostatin in mouse hypothalamic extracts: evidence of processing in vitro.

Authors:  M Lauber; M Camier; P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat.

Authors:  Y C Patel; S Reichlin
Journal:  Endocrinology       Date:  1978-02       Impact factor: 4.736

6.  Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat.

Authors:  O P Rorstad; J Epelbaum; P Brazeau; J B Martin
Journal:  Endocrinology       Date:  1979-11       Impact factor: 4.736

7.  Properties of somatostatin-like immunoreactive polypeptides in the canine extrahypothalamic brain and stomach.

Authors:  E S Zyznar; J M Conlon; V Schusdziarra; R H Unger
Journal:  Endocrinology       Date:  1979-12       Impact factor: 4.736

8.  Somatostatin precursors: evidence for presence in and release from rat median eminence and neurohypophysis.

Authors:  H H Zingg; Y C Patel
Journal:  Biochem Biophys Res Commun       Date:  1979-09-27       Impact factor: 3.575

9.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

10.  Somatostatin biosynthesis occurs in pancreatic islets.

Authors:  B D Noe; D J Fletcher; G E Bauer; G C Weir; Y Patel
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

View more
  5 in total

1.  A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.

Authors:  Y C Patel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 2.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

3.  Biosynthesis of somatostatin in canine fundic D cells.

Authors:  T Chiba; J Park; T Yamada
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Direct role of furin in mammalian prosomatostatin processing.

Authors:  A S Galanopoulou; N G Seidah; Y C Patel
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

5.  Plasma somatostatin 28 increases in response to feeding in man.

Authors:  K S Polonsky; S E Shoelson; H M Docherty
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.